Catatonia is a complex neuropsychiatric syndrome characterised by abnormal psychomotor disturbance, which poses a diagnostic and treatment challenge to clinicians. It is a life-threatening condition in its severe form, termed malignant and characterised by hyperthermia and autonomic disturbances. Early recognition and treatment are important in its management. A screening instrument, such as the Bush-Francis Catatonia Rating Scale (BFCRS), can help the clinician make a prompt diagnosis. Only a few published cases describe zolpidem being used to treat this condition, with lorazepam and electroconvulsive therapy (ECT) more commonly utilised as part of established treatment protocols. We discuss a case of a 70-year-old female with treatment-resistant depression and catatonic features who was successfully managed with zolpidem. This report highlights the role and efficacy of zolpidem in the clinical management of catatonia.
No takes yet. Share an insight, caveat, or question.
Yakubu et al. (2024) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: